000 01444 a2200385 4500
005 20250513145320.0
264 0 _c19981008
008 199810s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.42.7.1756
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVenkateswarlu, K
245 0 0 _aNADPH cytochrome P-450 oxidoreductase and susceptibility to ketoconazole.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cJul 1998
300 _a1756-61 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntifungal Agents
_xmetabolism
650 0 4 _aCatalysis
650 0 4 _aCell Line, Transformed
650 0 4 _aCytochrome P-450 Enzyme System
_xmetabolism
650 0 4 _aGenetic Complementation Test
650 0 4 _aHeterogeneous-Nuclear Ribonucleoproteins
650 0 4 _aKetoconazole
_xmetabolism
650 0 4 _aNADPH-Ferrihemoprotein Reductase
_xgenetics
650 0 4 _aOxidoreductases
_xmetabolism
650 0 4 _aRNA-Binding Protein FUS
650 0 4 _aRibonucleoproteins
_xmetabolism
650 0 4 _aSaccharomyces cerevisiae
_xenzymology
650 0 4 _aSterol 14-Demethylase
700 1 _aKelly, D E
700 1 _aManning, N J
700 1 _aKelly, S L
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 42
_gno. 7
_gp. 1756-61
856 4 0 _uhttps://doi.org/10.1128/AAC.42.7.1756
_zAvailable from publisher's website
999 _c9627059
_d9627059